glycopyrrolate
glycopyrrolate is listed in the FDA National Drug Code directory with 39 NDC codes, marketed under brand names including GLYCOPYRROLATE, Glycopyrrolate, glycopyrrolate. Available dosage forms: injection, tablet, solution, injection, solution, liquid.
Drug Details
- Generic Name
- glycopyrrolate
- Brand Names
- GLYCOPYRROLATE, Glycopyrrolate, glycopyrrolate, GLYRX-PF, Cuvposa
- Application Number
- ANDA210927
- Sponsor
- Solco Healthcare US, LLC
- NDC Codes
- 39
- Dosage Forms
- INJECTION, TABLET, SOLUTION, INJECTION, SOLUTION, LIQUID
- Routes
- INTRAMUSCULAR, INTRAVENOUS, ORAL
- Active Ingredients
- GLYCOPYRROLATE
Indications and Usage
1 INDICATIONS AND USAGE Glycopyrrolate oral solution is indicated to reduce chronic severe drooling in patients aged 3 to 16 years with neurologic conditions associated with problem drooling (e.g., cerebral palsy). Glycopyrrolate is an anticholinergic indicated to reduce chronic severe drooling in patients aged 3 to 16 years with neurologic conditions associated with problem drooling (e.g., cerebral palsy). ( 1 )